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A B S T R A C T
We report a female patient who repeatedly developed
pancreatitis after trimethoprim-sulfamethoxazole
(TMP/SMX) use. During childhood she had undergone
an ureterosigmoidostomy after which she had been on
TMP/SMX 480 mg daily as prophylaxis for pyelonephritis
for many years. The patient presented with abdominal
pain caused by acute pancreatitis. No other cause, except
for TMP/SMX use, could be identified. A causal relation-
ship was confirmed by relapse of the pancreatitis after
rechallenge. Our case is unique in demonstrating that acute
pancreatitis related to the use of TMP/SMX may occur even
after long-term treatment. We advise that the medication
is discontinued immediately if a causal relationship with
pancreatitis is suspected.
K E Y W O R D S
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I N T R O D U C T I O N
Drug-related acute pancreatitis remains an uncommon
clinical entity. Some cases of pancreatitis associated with
the use of trimethoprim-sulfamethoxazole (TMP/SMX)
have been reported previously (table 1).1-6 In all of these,
clinical symptoms occurred within days to weeks after the
onset of treatment. We report a case that is unique in that
acute pancreatitis occurred after many years of treatment
with TMP/SMX. Furthermore, a causal relation was demon-
strated by recurrent symptoms following drug rechallenge.
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Table 1 Documented case reports of TMP/SMX-induced acute pancreatitis
Reference Indication for Daily TMP/SMX Onset (days) of Onset of pancreatitis 
TMP/SMX use treatment (mg) pancreatitis after after rechallenge
start of TMP/SMX
1 Occipital abscess with 960/4800 7 3
Nocardia asteroids
2 Urinary tract infection 320/1600 Only hepatitis after ‘Several days’ (hepatitis 
first exposure and pancreatitis)
3 Ear infection 320/1600 5 No rechallenge
4 Occipital abscess with 1600/8000 42 No rechallenge
Nocardia
5 Pneumocystis carinii 1280/6400 10 No rechallenge
pneumonia (HIV pos.)
6 Pneumocystis carinii 900 6 No rechallenge
pneumonia (HIV pos.)
C A S E  R E P O R T
A 53-year-old woman presented with epigastric pain, radiating
to the back. Her history revealed an ureterosigmoidostomy
performed at the age of four years, according to the Coffey
technique, because of extrophia vesicae. Next, she developed
numerous episodes of pyelonephritis for which treatment
with prophylactic antibiotics in the form of TMP/SMX
(480 mg daily) had been initiated more than twenty years
before. In addition, in later years hyperthyroidism and
ulcerative colitis were diagnosed. Also, she developed a
prolapsed uterus for which vaginal surgery was performed.
At the time of presentation, she was not taking any drugs
other than TMP/SMX. 
The patient complained of continuous, left-sided epigastric
pain, radiating to the back, which had been present for
four days. The pain reminded her of an episode, one year
earlier, during which she suffered from epigastric pain
and nausea that increased after eating. At that time, the
serum amylase had been normal.
During the current episode of epigastric pain she did not
report nausea, vomiting or weight loss, and she had a
good appetite. There was no alcohol or nicotine abuse.
Physical examination was not remarkable, except for a mild
tenderness in the epigastric region and some percussion
pain in the left kidney region. There was no hepato-
splenomegaly. Laboratory evaluation revealed an increase
in the serum amylase, a metabolic acidosis and symptoms
of inflammation (table 2). Other routine laboratory values
were normal. Plain abdominal X-ray only showed a colon
filled with faeces. Abdominal ultrasonography was not
remarkable except for a uterus myomatosis. The pancreas
could not be visualised due to air-filled intestines.
Gastroduodenoscopy showed no abnormalities, especially
not in the peripapillary region. Therefore, the diagnosis
of acute pancreatitis was made. The patient was treated
conservatively (nil by mouth) and received paracetamol
1 g/6 h, as a suppository, for pain relief. Bicarbonate was
provided to correct the metabolic acidosis, which was
ascribed to bicarbonate loss through the ureterosigmoidos-
tomy. TMP/SMX was continued. The clinical condition
improved within three days and the CRP and serum amylase
level decreased to 124 mg/l and 151 U/l respectively. On
the fourth day the patient was discharged. A magnetic
resonance cholangiopancreatography (MRCP), which was
performed after discharge, showed no abnormalities,
especially no bile stones. The pain gradually decreased.
Since pancreatitis can be caused by TMP/SMX, this anti-
biotic was replaced by ciprofloxacin. Eventually, the
abdominal symptoms disappeared completely. 
After some weeks of treatment with ciprofloxacin, the
patient developed headaches, diarrhoea, fever and swollen
axillary glands. Ciprofloxacin was stopped and TMP/SMX
(480 mg twice a day) restarted. The serum amylase level
was normal (156 U/l) on the day treatment was restarted
(day 1, episode 3, figure 1). Within four days the epigastric
pain recurred and the amylase level again increased to
1161 U/l (day 5, episode 3, figure 1). The diagnosis of a
relapse of acute pancreatitis was made. TMP/SMX was now
replaced by amoxicillin-clavulanic acid. After two days,
the serum amylase decreased to 245 U/l and the epigastric
pain disappeared. Because the patient developed abdominal
discomfort while taking amoxicillin-clavulanic acid,
trimethoprim was prescribed. In the following months
she did not take any sulphonamides and did not have any
further episodes of epigastric pain.
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Table 2 Laboratory values at admission (day one,
episode two)
CRP 141 mg/l 
Amylase 782 (<220) U/l
pH 7.31 
pO2 11.6 kPa
pCO2 5.1 kPa
Bicarbonate 18.9 mmol/l
Base excess -6.8 mmol/l 
Calcium 2.44 (2.20-2.60) mmol/l
Triglycerides 0.71 (0.8-2.0) mmol/l
Alkaline phosphatase 68 (<120) U/l
ASAT 25 (<40) U/l
ALAT 15 (<45) U/l
GT 14 (<35) U/l
Normal values are given between brackets. CRP = C-reactive protein;
ASAT = aspartate aminotranspeptidase; ALAT = alanine amino-
transpeptidase; GT = gamma glutamyl transpeptidase.
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Figure 1 Serum amylase (Y-axis) in time in the
absence or presence of TMP/SMX exposure
Since serum amylase was normal in the first episode of epigastric
pain, this episode is not shown in the figure. Time between episode
two and three is approximately two months. Day one of the second
episode represents the visit to the emergency department because
of epigastric pain. Day one of the third episode represents the day
of restarting TMP/SMX.
D I S C U S S I O N
Drugs are classified as having a definite relation with the
development of pancreatitis if there is a temporal relation-
ship between drug administration and the signs and
symptoms of pancreatitis or a positive response to direct
(re)challenge with the drug.7 Previous case reports have
demonstrated/suggested an association between pancreatitis
and TMP/SMX (table 1).1-6 Sulfamethoxazole is generally
held responsible since sulphonamide derivates have been
associated with pancreatitis while trimethoprim alone has
not.8,9 A definite causal relationship between sulfamethoxa-
zole administration and pancreatitis, shown by rechallenge,
has only been demonstrated in a few cases.1,8 The pancre-
atitis-inducing mechanism remains unclear. An allergic
reaction has been assumed.8
Here we report a patient who developed acute pancreatitis
after having taken TMP/SMX for many years as prophylaxis
for pyelonephritis. During her first episode of epigastric
pain, the diagnosis of acute pancreatitis was considered,
but based on her clinical condition and a normal serum
amylase level, measured four days after the first symptoms,
a diagnosis of gastric ulceration seemed more likely.
Retrospectively, it seems probable that our patient had
already suffered a bout of acute pancreatitis during that
episode. During her second episode of epigastric pain,
serum amylase levels were definitely elevated and acute
pancreatitis was diagnosed. Known causes of acute pan-
creatitis include alcohol abuse, cholelithiasis, hyperlipi-
daemia, hypercalcaemia, pancreatic trauma, viral infections
and drugs. Based on a negative history of alcohol abuse
and pancreatic trauma, normal values of liver enzymes,
triglycerides and calcium, and the absence of ulcers, bile
stones and other liver or bile duct abnormalities on a
plain abdominal X-ray, abdominal ultrasonography, gastro-
duodenoscopy and MRCP, all of the above-mentioned
causes could be excluded with the exception of drugs.
This is supported by the fact that discontinuation of TMP/
SMX treatment resulted in her symptoms disappearing
completely. However, a causal relationship was finally
confirmed when we observed a relapse of acute pancreatitis
within four days of restarting TMP/SMX because of adverse
effects to prophylaxis with ciprofloxacin. Since trimethoprim
alone has not been associated with acute pancreatitis, we
eventually decided to use trimethoprim as a prophylactic
drug for pyelonephritis.
The interval between starting the cotrimoxazole and the
onset of pancreatitis was long. For various drugs it is well
known that complications do not occur immediately after
the start of the drug therapy, as for instance for azathioprine.
In a recent review paper it was stated that ‘Cutaneous
reactions are hypersensitivity reactions and they usually
manifest immediately after exposure or re-exposure to the
drug, unlike other adverse reactions, which might only
manifest at high doses or after prolonged therapy’.10 The
absence of a rash in the patient presented in this paper
does not support the hypothesis of a hypersensitivity
reaction as the cause of the pancreatitis.
Our case is unique in that it demonstrates a definite causal
relationship between acute pancreatitis and TMP/SMX in
a patient who had been taking this antibiotic continuously
for more than 20 years. Based on this experience, we
advise that this medication is immediately discontinued if
a causal relationship with pancreatitis is highly suspected.
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